Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Louise‐Ann Leyland
Observed names:
L. Leyland,
L.-A. Leyland,
Leyland, Louise-Ann,
Louise Ann Leyland,
Louise-Ann Leyland
Institutions:
UCL Queen Square Institute of Neurology,
University College London
Observed institutions:
Wellcome Centre for Human Neuroimaging,
University of Southampton,
UCL Queen Square Institute of Neurology,
University College London,
University of Reading
ORCID:
0000-0001-6130-6108
Observed ORCID:
0000-0001-6130-6108
OpenAlex ID:
A5049914115
Brain iron deposition is linked with cognitive severity in Parkinson’s disease
2020
·
George Edward Calver Thomas
, Louise Ann Leyland
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
229
The effect of cycling on cognitive function and well-being in older adults
2019
·
Louise-Ann Leyland
, Ben Spencer
, et al.
·
PLoS ONE
·
180
PDF
Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson’s disease
2021
·
George E C Thomas
, Angeliki Zarkali
, et al.
·
Brain
·
123
PDF
Sequence of clinical and neurodegeneration events in Parkinson’s disease progression
2021
·
Neil P Oxtoby
, Louise-Ann Leyland
, et al.
·
Brain
·
108
A Clinically Interpretable Computer-Vision Based Method for Quantifying Gait in Parkinson’s Disease
2021
·
Samuel Rupprechter
, Gareth Morinan
, et al.
·
Sensors
·
96
PDF
Organisational and neuromodulatory underpinnings of structural-functional connectivity decoupling in patients with Parkinson’s disease
2021
·
Angeliki Zarkali
, Peter McColgan
, et al.
·
Communications Biology
·
91
PDF
Increased weighting on prior knowledge in Lewy body-associated visual hallucinations
2019
·
Angeliki Zarkali
, Rick A Adams
, et al.
·
Brain Communications
·
72
PDF
Computer vision quantification of whole-body Parkinsonian bradykinesia using a large multi-site population
2023
·
Gareth Morinan
, Yuriy Dushin
, et al.
·
npj Parkinson s Disease
·
71
PDF
Fiber-specific white matter reductions in Parkinson hallucinations and visual dysfunction
2020
·
Angeliki Zarkali
, Peter McColgan
, et al.
·
Neurology
·
69
PDF
Visual Dysfunction Predicts Cognitive Impairment and White Matter Degeneration in Parkinson's Disease
2021
·
Angeliki Zarkali
, Peter McColgan
, et al.
·
Movement Disorders
·
61
PDF
Differences in network controllability and regional gene expression underlie hallucinations in Parkinson’s disease
2020
·
Angeliki Zarkali
, Peter McColgan
, et al.
·
Brain
·
59
PDF
Visual tests predict dementia risk in Parkinson disease
2020
·
Louise-Ann Leyland
, Fion D. Bremner
, et al.
·
Neurology Clinical Practice
·
56
PDF
Computer-vision based method for quantifying rising from chair in Parkinson's disease patients
2021
·
Gareth Morinan
, Yuwei Peng
, et al.
·
Intelligence-Based Medicine
·
45
Changes in dynamic transitions between integrated and segregated states underlie visual hallucinations in Parkinson’s disease
2022
·
Angeliki Zarkali
, Andrea I. Luppi
, et al.
·
Communications Biology
·
40
PDF
Longitudinal thalamic white and grey matter changes associated with visual hallucinations in Parkinson’s disease
2021
·
Angeliki Zarkali
, Peter McColgan
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
33
PDF
Visual dysfunction is a better predictor than retinal thickness for dementia in Parkinson’s disease
2023
·
Naomi Hannaway
, Angeliki Zarkali
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
32
PDF
‘Instead of “closing down” at our ages … we’re thinking of exciting and challenging things to do’: older people’s microadventures outdoors on (e-)bikes
2019
·
Ben Spencer
, Tim Jones
, et al.
·
Journal of Adventure Education & Outdoor Learning
·
32
PDF
Neural correlates of early cognitive dysfunction in Parkinson's disease
2019
·
Rimona S. Weil
, Joel S. Winston
, et al.
·
Annals of Clinical and Translational Neurology
·
27
PDF
Neglect Patients Exhibit Egocentric or Allocentric Neglect for the Same Stimulus Contingent upon Task Demands
2017
·
Louise-Ann Leyland
, Hayward J. Godwin
, et al.
·
Scientific Reports
·
18
PDF
Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson’s patients
2024
·
Laura de Boni
, Amber Wallis
, et al.
·
EMBO Molecular Medicine
·
14
PDF
Dementia risk in Parkinson’s disease is associated with interhemispheric connectivity loss and determined by regional gene expression
2020
·
Angeliki Zarkali
, Peter McColgan
, et al.
·
NeuroImage Clinical
·
13
PDF
The influence of word shading and word length on eye movements during reading
2011
·
Louise-Ann Leyland
, Julie A. Kirkby
, et al.
·
Quarterly Journal of Experimental Psychology
·
11
“You can go out 14 miles away with the knowledge that you’ve got the battery to help you back if you need it!” Narratives of ranging behaviour and wellbeing in diaries of e-bike trial participants.
2021
·
Tim Jones
, Ben Spencer
, et al.
·
Active Travel Studies
·
6
PDF
Examining the role of future time perspective and age-related differences in the neural time course of emotional processing and memory
2023
·
J. Raw
, L. Leyland
, et al.
·
International Journal of Psychophysiology
·
2
Visual dysfunction predicts cognitive impairment and white matter degenera- tion in Parkinson’s disease
2022
·
Angeliki Zarkali
, Peter McColgan
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
1
Show more works
View as search
Works count:
34
Citation count:
1,490
H-index:
18
I10-index:
22
Year
Topic
Type